TW201613911A
(en )
2016-04-16
Heterocyclic compounds and uses thereof
DK3529248T3
(en )
2020-09-14
Pharmaceutical compositions
BR112017004612A2
(en )
2018-01-30
compounds, pharmaceutical composition, uses of a compound, and kit
MA54411A
(en )
2021-10-13
COMPOSITIONS CONTAINING IBRUTINIB
EA201790785A1
(en )
2017-10-31
Derivatives of tetrahydroisoquinoline
EA201591728A1
(en )
2016-01-29
HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION
DK3116491T3
(en )
2021-08-09
PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC ACTIVE COMPOUNDS
DK3821905T3
(en )
2022-11-14
PHARMACEUTICAL COMPOSITIONS CONTAINING INSULIN
MA44987A
(en )
2019-03-20
ENHANCED DRUG FORMULATIONS
CO2017001389A2
(en )
2017-05-10
Azetidinyloxyphenylpyrrolidine compounds
DK3583943T3
(en )
2024-10-14
PHARMACEUTICAL COMPOSITION
MA49837A
(en )
2020-06-17
PHARMACEUTICAL COMPOSITIONS
TR201901516T4
(en )
2019-02-21
Neuroprotective agents and their uses.
DK3886820T3
(en )
2023-05-15
Capsule formulations
DK3256138T3
(en )
2022-05-16
PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM
DE112018002289A5
(en )
2020-04-16
Garter
FR3025096B1
(en )
2016-12-23
GEL / GEL COMPOSITION CONTAINING ANTI-TRANSPARENT ACTIVE INGREDIENT
MA42048A
(en )
2018-03-14
AMINOESTERS DERIVATIVES
DK3728220T3
(en )
2022-02-07
Pharmaceutical compounds
MA49625A
(en )
2020-05-27
PHARMACEUTICAL COMPOSITIONS
UA100710U
(en )
2015-08-10
APPLICATION OF FITOVENOL Capsules AS A HEPATOPROTECTOR
DK3558261T3
(en )
2022-06-20
PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE
IT201700090331A1
(en )
2019-02-08
"LOPEMIDE"
IT201700071679A1
(en )
2018-12-27
REMEMBEBE '
EA201991993A1
(en )
2020-01-15
APPLICATION OF PHENYLCREATIN AS A NOOTROPIC AGENT